by Brooke Blazr | Jan 7, 2026 | High Dispatch
Researchers analyzed HIV patients—one of the most medically vulnerable populations you can study—and found that cannabis use was not associated with heart abnormalities. Let me repeat that for the people in the back: not associated with heart...
by Brooke Blazr | Jan 6, 2026 | High Dispatch
Cannabis is one of the best natural therapies out there for ADHD, but it should be used with careful thought and caution. Keep in mind that the very same product that can help improve focus for someone with ADHD can cause another to get derailed if the timing or...
by Brooke Blazr | Jan 5, 2026 | High Dispatch
Given there are serious limitations to pharmaceutical cannabinoid medications, it’s clear that the problem lies in the insurance system that has yet to evolve alongside patients’ needs and medical science. There is a clear disconnect when insurance companies...
by Brooke Blazr | Jan 4, 2026 | High Dispatch
Take cannabis, for example—my favorite barometer for societal sanity. We went from “this will literally destroy your brain and turn you into a violent criminal” to “okay maybe it’s medicine” to “actually it’s legal in half...
by Brooke Blazr | Jan 2, 2026 | High Dispatch
Dry January is no longer just a detox. What began as a post-holiday pause from drinking has evolved into a cultural reassessment of how people relax, socialize, and manage stress. Each January, millions of Americans step back from alcohol not simply to recover from...
by Brooke Blazr | Jan 2, 2026 | High Dispatch
Furthermore, Schedule III could mean that independent researchers—not just pharma shills—might finally get a seat at the table. Universities won’t have to fear losing their funding just for touching the plant. We might see a new wave of “less...